SLDB
SLDB
NASDAQ · Biotechnology

Solid Biosciences Inc

$6.64
+0.36 (+5.73%)
As of Nov 7, 2:02 AM ET ·
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 18 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +64.2% upside
Low Target $9.47
Average Target $10.90
High Target $14.24
Current Price $6.64
Current
$6.64
Target
$10.90
$9.47 $10.90 avg $14.24
Scenario Analysis
Bear Case
$9.47
42.6%
Low target
Base Case
$10.90
+64.2%
Avg target
Bull Case
$14.24
+114.5%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$11.45
-42.0% from high
52-Week Low
$3.79
+75.2% from low
Target vs 52W High
$10.90
-4.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -40.7%